Admedus Buy Hold or Sell Recommendation

AMEUF -- USA Stock  

USD 0.26  0.00  0.00%

Assuming 30 trading days horizon, and your above average risk tolerance our recommendation regarding Admedus Limited is 'Cautious Hold'. Macroaxis provides Admedus buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Admedus positions. The advice algorithm takes into account all of Admedus Limited available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Admedus buy-and-hold prospective. Check also Admedus Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell AdmedusBuy Admedus
Strong Sell

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon Admedus Limited has a mean deviation of 12.96, semi deviation of 0.0, standard deviation of 30.08, variance of 904.93, downside variance of 0.0 and semi variance of 0.0
We provide buy or sell advice to complement the prevailing expert consensus on Admedus Limited. Our dynamic recommendation engine makes use of multi - dimensional algorithm to analyze the company potential to grow using all technical and fundamental data available at the time. To make sure Admedus is not overpriced, please confirm all Admedus Limited fundamentals including its Debt to Equity, Total Asset and the relationship between Net Income and Earnings Per Share . As Admedus Limited appears to be a penny stock we also recommend to validate its Price to Book numbers.

Admedus Returns Distribution Density

Mean Return3.74Value At Risk0.00
Potential Upside33.33Standard Deviation30.08
 Return Density 

Admedus Greeks

Alpha over DOW
Beta against DOW=3.67
Overall volatility
Information ratio =0.12

Admedus Volatility Alert

Admedus Limited is displaying above average volatility of 30.08 over selected time horizon. Investors should scrutinize Admedus Limited independently to make sure intended market timing strategies are aligned with expectations about Admedus volatility. Admedus Limited is a potential penny stock. Although Admedus may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial stock hype. Please make sure you totally understand upside potential and downside risk of investing in Admedus Limited. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings,sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
 Better Than Average     
 Worse Than Average Compare Admedus to competition

Admedus Fundamental Vs Peers

FundamentalsAdmedusPeer Average
Return On Equity(65.41) % (15.17) %
Return On Asset(35.80) % (15.64) %
Profit Margin(68.01) % (5.50) %
Operating Margin(83.35) % (10.91) %
Current Valuation74.29 M152.14 B
Shares Outstanding254.8 M1.43 B
Price to Earning3.20 times40.69 times
Price to Book9.63 times14.44 times
Price to Sales2.21 times17.81 times
Revenue15.81 M9.85 B
Gross Profit10.29 M21.75 B
EBITDA(11.83 M)1.41 B
Net Income(10.75 M)517.71 M
Cash and Equivalents3.27 M3.89 B
Cash per Share0.01 times5.17 times
Total Debt3.29 M7.36 B
Debt to Equity40.60 % 0.72 %
Current Ratio1.58 times3.30 times
Book Value Per Share0.03 times13.64 times
Cash Flow from Operations(7.18 M)1.25 B
Earnings Per Share0.04 times2.30 times
Number of Employees1210.67 K
Market Capitalization35.01 M29.78 B
Total Asset27 M126.86 B
Retained Earnings(69 M)38.24 B
Working Capital13 M3.58 B
Current Asset17 M36.8 B
Current Liabilities4 M33.34 B
Z Score3.2708.73

Admedus Alerts

Trading Alerts and Improvement Suggestions

Admedus Limited appears to be very risky and stock price may revert if volatility continues
Admedus Limited has some characteristics of a very speculative penny stock
The company reported revenue of 15.81 M. Net Loss for the year was (10.75 M) with profit before overhead, payroll, taxes, and interest of 10.29 M.
ADMEDUS has accumulated about 3.27 M in cash with (7.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Latest headline from Global Extracellular Matrix Patches Market 2018 Aziyo Biologics, Boston Scientific Corporation, Coloplast ...
Check also Admedus Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try ETF Directory module to find actively-traded exchange traded funds (etf) from around the world.